A handout photo shows an employee demonstrating a vial with "Gam-COVID-Vac" vaccine against the coronavirus disease (COVID-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), during its production at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. Picture taken August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS
MOSCOW (Reuters) - Russia is preparing to approve a second vaccine against COVID-19 in late September or early October, Russian Deputy Prime Minister Tatiana Golikova said on Wednesday.
Speaking at a televised government meeting, Golikova told President Vladimir Putin that early-stage clinical trials on the vaccine, developed by the Vector virology institute in Siberia, would be completed by the end of September.
Limited time offer:
Just RM5 per month.
